General Motors Financial Company, Inc. (A Company Incorporated in the State of Texas, United States of America) €10,000,000,000 Euro Medium Term Note Programme
Total Page:16
File Type:pdf, Size:1020Kb
General Motors Financial Company, Inc. (a company incorporated in the State of Texas, United States of America) €10,000,000,000 Euro Medium Term Note Programme Under the Euro Medium Term Note Programme described in this Base Prospectus (the “Programme”), General Motors Financial Company, Inc. (“GM Financial” and the “Issuer”), subject to compliance with all relevant laws, regulations and directives, may from time to time issue Euro Medium Term Notes (the “Notes”). The aggregate nominal amount of Notes outstanding under the Programme will not at any time exceed €10,000,000,000 (or the equivalent in other currencies at the time of issue). The Notes may be issued on a continuing basis to one or more of the Dealers specified under “Overview” and to any additional Dealer appointed under the Programme from time to time by the Issuer (each a “Dealer” and together the “Dealers”), which appointment may be for a specific issue or on an on-going basis. References in this Base Prospectus to the “relevant Dealer” shall, in the case of an issue of Notes being (or intended to be) subscribed by more than one Dealer, be to all Dealers agreeing to subscribe such Notes. The Notes will be issued in registered form. This Base Prospectus has been approved by the Central Bank of Ireland (the “Central Bank”) as competent authority under Regulation (EU) 2017/1129 (the “Prospectus Regulation”). The Central Bank only approves this Base Prospectus as meeting the standards of completeness, comprehensibility and consistency imposed by the Prospectus Regulation. Such approval should not be considered as an endorsement of the Issuer or of the quality of the Notes that are subject of this Base Prospectus. Investors should make their own assessment as to the suitability of investing in the Notes. Application will be made to the Irish Stock Exchange plc (trading as Euronext Dublin) (“Euronext Dublin”) for Notes issued under the Programme within 12 months of the date of approval of this Base Prospectus to be admitted to the official list (the “Official List”) and to trading on its regulated market (the “Regulated Market of Euronext Dublin”). The Regulated Market of Euronext Dublin is a regulated market for the purposes of Directive 2014/65/EU (as amended, “MiFID II”). Such approval relates only to Notes which are to be admitted to trading on a regulated market for the purposes of MiFID II. The applicable Final Terms (as defined below) in respect of the issue of any Notes will specify whether or not such Notes will be listed on the Official List and admitted to trading on the Regulated Market of Euronext Dublin (or any other stock exchange). The Programme provides that Notes may be listed or admitted to trading, as the case may be, on such other or further stock exchange(s) or markets as may be agreed between the Issuer and the relevant Dealer(s). The Issuer may also issue unlisted Notes and/or Notes not admitted to trading on any market. This Base Prospectus (as supplemented as at the relevant time, if applicable) is valid for 12 months from its date in relation to Notes which are to be admitted to trading on a regulated market in the European Economic Area (the “EEA”). The obligation to supplement this Prospectus in the event of a significant new factor, material mistake or material inaccuracy does not apply when this Prospectus is no longer valid. The requirement to publish a prospectus under the Prospectus Regulation only applies to Notes which are to be admitted to trading on a regulated market in the EEA and/or offered to the public in the European Economic Area other than in circumstances where an exemption is available under Article 1(4) and/or 3(2) of the Prospectus Regulation. References in this Base Prospectus to “Exempt Notes” are to Notes for which no prospectus is required to be published under the Prospectus Regulation. The Central Bank has neither approved nor reviewed information contained in this Base Prospectus in connection with Exempt Notes. The Notes have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the “Securities Act”), or any U.S. state securities laws, and may not be offered or sold in the United States of America or to, or for the account or benefit of, U.S. persons as defined in Regulation S under the Securities Act (“Regulation S”) unless an exemption from the registration requirements of the Securities Act is available and in accordance with all applicable securities laws of any state of the United States of America and any other jurisdiction. An investment in Notes issued under the Programme involves certain risks. See the section titled “Risk Factors”. The Programme has been rated BBB- by Fitch Ratings, Inc. (“Fitch”), Baa3 by Moody’s Investors Service, Inc. (“Moody’s”) and BBB by Standard & Poor’s Ratings Services (“S&P”). None of Fitch, Moody’s and S&P is established in the European Union (“EU”) or registered under Regulation (EC) No. 1060/2009 (as amended) (the “CRA Regulation”), but the ratings given to the Programme are endorsed by Fitch Ratings Ireland Limited, Moody’s Deutschland GmbH and S&P Global Ratings Europe Limited, respectively. Fitch Ratings Ireland Limited, Moody’s Deutschland GmbH and S&P Global Ratings Europe Limited are established in the EU and each is registered under the CRA Regulation. In addition, the ratings are endorsed by Fitch Ratings Ltd, Moody’s Investors Service Ltd and S&P Global Ratings UK Limited in accordance with Regulation (EC) No. 1060/2009 as it forms part of domestic law by virtue of the the European Union (Withdrawal) Act 2018 (“EUWA”) (the “UK CRA Regulation”) and have not been withdrawn. As such, the ratings issued by Fitch, Moody’s and S&P may be used for regulatory purposes in the EU and the United Kingdom in accordance with the CRA Regulation and the UK CRA Regulation respectively. Tranches (as defined herein) of Notes to be issued under the Programme may be rated or unrated. Where a Tranche of Notes is to be rated, such rating will not necessarily be the same as the ratings assigned to the Programme. Where a Tranche of Notes is rated, the applicable rating(s) will be specified in the applicable Final Terms or Pricing Supplement (as defined below) (as the case may be). Whether or not a rating in relation to any Tranche of Notes will be treated as having been issued by a credit rating agency established in the EU and registered under the CRA Regulation or established in the UK and registered under the UK CRA Regulation will be disclosed in the applicable Final Terms or Pricing Supplement (as the case may be). A security rating is not a recommendation to buy, sell or hold securities and may be subject to suspension, reduction or withdrawal at any time by the assigning rating agency. Arranger BNP PARIBAS Dealers BBVA Barclays BNP PARIBAS BofA Securities Citigroup Commerzbank Crédit Agricole CIB Deutsche Bank Goldman Sachs International ICBC Standard Bank ING IMI – Intesa Sanpaolo J.P. Morgan Lloyds Bank Corporate Markets Mizuho Securities Morgan Stanley RBC Capital Markets Santander Société Générale UniCredit Corporate & Investment Banking The date of this Base Prospectus is 2 June 2021. IMPORTANT INFORMATION This Base Prospectus comprises a base prospectus in respect of all Notes other than Exempt Notes issued under the Programme for the purposes of Article 8 of the Prospectus Regulation and for the purpose of giving information with regard to the Issuer, the Group, the business of the Group and the Notes which, according to the particular nature of the Issuer, the Group and the Notes, is necessary to enable investors to make an informed assessment of the assets and liabilities, financial position, profit and losses and prospects of each of the Issuer and the Group and the rights attaching to the Notes. As used in this Base Prospectus, the term “Group” shall be taken to refer to GM Financial and its subsidiaries on a consolidated basis. Notice of the aggregate nominal amount of Notes, interest (if any) payable in respect of Notes, the issue price of Notes and certain other information which is applicable to each Tranche of Notes (other than in the case of Exempt Notes) will be set out in a final terms document (the “Final Terms”), which will be filed with the Central Bank. Copies of Final Terms in relation to Notes to be listed on Euronext Dublin will also be published on Euronext Dublin’s website (https://live.euronext.com/). In the case of Exempt Notes, notice of the aggregate nominal amount of Notes, interest (if any) payable in respect of Notes, the issue price of Notes and certain other information which is applicable to each Tranche will be set out in a pricing supplement document (the “Pricing Supplement”). The Issuer may agree with any Dealer and the Fiscal Agent (as defined herein) that Notes may be issued in a form not contemplated by the Terms and Conditions of the Notes (the “Conditions”), in which event (in the case of Notes other than Exempt Notes) a drawdown prospectus to this Base Prospectus may be made available which will describe the effect of the agreement reached in relation to such Notes (a “Drawdown Prospectus”). The Issuer accepts responsibility for the information contained in (and incorporated by reference in) this Base Prospectus and the Final Terms or Pricing Supplement (as the case may be) for each Tranche of Notes issued under the Programme. To the best of the knowledge of the Issuer, the information contained in (and incorporated by reference in) this Base Prospectus is in accordance with the facts and this Base Prospectus makes no omission likely to affect its import.